Education
About Us
Working with TipRanks
Follow Us
Jonathan Biller Insider Profile
4 Followers
Jonathan Biller, EVP & GC at Celgene, holds 15.65K shares in Vertex Pharmaceuticals (Ticker: VRTX), holds 22.95K shares in Agios Pharma (Ticker: AGIO), holds 7.14K shares in Celgene (Ticker: CELG).
Jonathan Biller Celgene (CELG)EVP & GC
Celgene (CELG)
EVP & GC
Not Ranked
Jonathan Biller has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jonathan Biller holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Jonathan Biller
Jonathan Biller's Trading History
Celgene
Nov 22, 2019
―
Uninformative Buy
―
$773.16K
Agios Pharma
Feb 23, 2022
CFO
Uninformative Buy
171.67K
$953.01K
Vertex Pharmaceuticals
Oct 03, 2025
EVP & CLO
Uninformative Sell
280.52K
$6.40M
List of latest transactions for each holding click on a transaction to see Jonathan Biller's performance on stock
You May Also Like
Jonathan Biller insider profile FAQ
What is the percentage of profitable transactions made by Jonathan Biller?
The percentage of profitable transactions made by Jonathan Biller is ―.
What is the average return per transaction made by Jonathan Biller?
The average return per transaction made by Jonathan Biller is ―.
What stocks does Jonathan Biller hold?
Jonathan Biller holds: CELG, AGIO, VRTX stocks.
What was Jonathan Biller’s latest transaction?
Jonathan Biller latest transaction was an Uninformative Sell of $280.52K.
What was Jonathan Biller's most profitable transaction?
Jonathan Biller’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Jonathan Biller's role in Celgene?
Jonathan Biller's role in Celgene is EVP & GC.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.